Generic Cymbalta gets tentative FDA approval
Sun Pharma Generic Cymbalta gets tentative FDA approval.
Sun Pharmaceutical Industries, an Indian Pharma, said that the US Food and Drug Administration has granted its subsidiary a tentative approval for an abbreviated new drug application (ANDA) to market a generic version of Cymbalta, duloxetine hydrochloride delayed-release capsules.
Buy Generic Cymbalta
The Indian Generic Cymbalta strength are: 20mg (base), 30mg (base), and 60mg (base) are indicated in the treatment of major depressive disorder (MDD), generalised anxiety disorder (GAD) and diabetic peripheral neuropathic pain (DPNP).
Duloxetine (Cymbalta, Ariclaim, Xeristar, Yentreve) is a serotonin-norepinephrine reuptake inhibitor manufactured and marketed by Eli Lilly.
More fact about Duloxetine from WikiPedia
Related posts:
- FDA Approves Duloxetine for Chronic Musculoskeletal Pain US FDA Approves Duloxetine for Chronic Musculoskeletal Pain On November...
- Cymbalta Cymbalta (DULOXETINE) is an antidepressant recently approved by the FDA...
